Retraction: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Q56648755)
Jump to navigation
Jump to search
scientific article published on 14 September 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Retraction: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF |
scientific article published on 14 September 2018 |
Statements
Retraction: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (English)
0 references
14 September 2018
0 references
15 September 2018
0 references
78
0 references
18
0 references
5466-5466
0 references
5466
0 references